Skip to content
Screener

Tectonic Therapeutics TECX Total Liabilities & Equity

Total Liabilities & Equity at other companies

ALN
Alnylam PharmaceuticalsALNY
$5.56B+21.7%
Septerna, Inc. logo
Septerna, Inc.SEPN
$566.74M+36.5%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$199.26M+30.5%
Regenxbio logo
RegenxbioRGNX
$386.62M-33.5%
Opko Health logo
Opko HealthOPK
$1.83B-7.3%
Celcuity logo
CelcuityCELC
$410.16M+88.0%

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$639.46M+54.6%
Enterprise value$407.46M+219%

Returns & leverage

See full
Return on equity-31.4%—
Debt / equity0×0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Tectonic Therapeutics’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:19 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-212016
Line itemMarch 31, 2026December 31, 2025
Commitments and contingencies (Note 10)
Stockholders’ Equity:
Common stock, $0.0001 par value; 150,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 18,830,436 and 18,738,249 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively22
Additional paid-in capital478,393474,160
Accumulated other comprehensive loss—(96)
Accumulated deficit(247,978)(222,737)
Total stockholders’ equity230,417251,329
Total liabilities and stockholders’ equity$246,577$261,038

Item 1. Financial Statements.

FAQ

What is Tectonic Therapeutics's total liabilities & equity?
Tectonic Therapeutics (TECX) reported total liabilities & equity of $246.58M in Q1 2026.
How has Tectonic Therapeutics's total liabilities & equity changed year-over-year?
Tectonic Therapeutics's total liabilities & equity decreased by 21.7% year-over-year, from $314.83M to $246.58M.
What is the long-term trend for Tectonic Therapeutics's total liabilities & equity?
Over 5 years (2020 to 2025), Tectonic Therapeutics's total liabilities & equity has grown at a -0.8% compound annual growth rate (CAGR), from $271.23M to $261.04M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Tectonic Therapeutics's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude